| Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES | Journal of Controlled Release |  | | 2019 | 273 | 777 |
|
| Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTES | International Journal of Pharmaceutics |  | | 2019 | 228 | 2 |
|
| Pharmacokinetics of the Protein Microbicide 5P12-RANTES in Sheep following Single-Dose Vaginal Gel Administration | Antimicrobial Agents and Chemotherapy | | | 2017 | 457 | 1 |
|
| Stability of 5P12-RANTES, A Candidate Rectal Microbicide, in Human Rectal Lavage | AIDS Research and Human Retroviruses | | | 2017 | 404 | 0 |
|
| A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastoris | Protein expression and purification | | | 2016 | 588 | 344 |
|
| Using glycosaminoglycan/chemokine interactions for the long-term delivery of 5P12-RANTES in HIV prevention | Molecular pharmaceutics | | | 2013 | 630 | 538 |
|
| CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity | Journal of virology |  | | 2012 | 639 | 0 |
|
| Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use | PloS one | | | 2011 | 730 | 320 |
|
| Circulating human CD4 and CD8 T cells do not have large intracellular pools of CCR5 | Blood | | | 2011 | 586 | 0 |
|
| "Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1SF162 or simian-human immunodeficiency virus SHIVSF162-p3 do not confer resistance | Journal of virology | | | 2010 | 647 | 36 |
|
| Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challenge | The Journal of infectious diseases | | | 2009 | 638 | 1 |
|
| Chemokine analogues show suitable stability for development as microbicides | Journal of acquired immune deficiency syndromes | | | 2008 | 623 | 2 |
|
| Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4 | Protein engineering, design & selection | | | 2008 | 680 | 8 |
|
| Semisynthetic analogues of PSC-RANTES, a potent anti-HIV protein | Bioconjugate chemistry | | | 2008 | 718 | 5 |
|
| Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide | Proceedings of the National Academy of Sciences of the United States of America | | | 2008 | 624 | 2 |
|
| Microbicides and other topical strategies to prevent vaginal transmission of HIV | Nature reviews. Immunology | | | 2006 | 611 | 0 |
|
| Engineering chemokines to develop optimized HIV inhibitors | Current protein and peptide science | | | 2005 | 597 | 0 |
|
| Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors | Proceedings of the National Academy of Sciences of the United States of America | | | 2004 | 719 | 1 |
|
| PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes | Journal of virology | | | 2004 | 683 | 0 |
|
| Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5 | Science | | | 2004 | 665 | 1 |
|
| Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES | Antimicrobial agents and chemotherapy | | | 2003 | 668 | 108 |
|
| Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines | Journal of virology | | | 2003 | 561 | 396 |
|
| Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression | Journal of virology | | | 2001 | 643 | 1 |
|
| Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs | Journal of virology | | | 2000 | 591 | 2 |
|
| Amino acid sequence determination by gas chromatography—mass spectrometry of permethylated peptides | Journal of chromatography | | | 1983 | 724 | 0 |
|
| Inhibition of degradation of insulin by ophthalamic acid and by a bovine pancreatic proteinase inhibitor | Biochemical journal | | | 1979 | 647 | 0 |
|
| The degradation of semisynthetic tritiated insulin by perfused mouse livers | Biochemical journal | | | 1976 | 592 | 0 |
|
